L'Elranatamab de Pfizer reçoit la désignation de thérapie révolutionnaire de la FDA pour le myélome multiple récidivant ou réfractaire.
L'Elranatamab de Pfizer reçoit la désignation de thérapie révolution…
Nov 3, 2022
zonebourse.com
Pfizer's Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
Pfizer's Elranatamab Granted FDA Breakthrough Therapy Designatio…
Nov 3, 2022
marketscreener.com
Dr Mohty on the Real-World Efficacy of Elranatamab in R/R Multiple Myeloma | OncLive
1:59
Dr Mohty on the Real-World Efficacy of Elranatamab in R/R Multiple My…
1 week ago
onclive.com
Dr Mohty on the Implications of Real-World Efficacy With Elranatamab in R/R Myeloma | OncLive
Dr Mohty on the Implications of Real-World Efficacy With Elranata…
Jul 2, 2024
onclive.com
Pfizer : désignation 'Fast Track' de la FDA pour elranatamab
Pfizer : désignation 'Fast Track' de la FDA pour elranatamab
Feb 17, 2021
zonebourse.com
Clinical Insights on the Efficacy and Safety of Bispecific Antibodies in Multiple Myeloma | AJMC
Clinical Insights on the Efficacy and Safety of Bispecific Antibodies in …
1 month ago
ajmc.com
Elranatamab (ELREXFIO) - a BCMA x CD3 Bispecific Antibody for Multiple Myeloma
27:16
Elranatamab (ELREXFIO) - a BCMA x CD3 Bispecific Antibody for Mult…
2.2K viewsFeb 6, 2024
YouTubeHealthTree University for Multiple Myeloma
1:45
Using the available repertoire of bispecific antibodies for treating …
104 viewsFeb 26, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
7:06
Efficacy and safety of elranatamab BCMA-CD3 bispecific antibody, in …
1.1K viewsJun 14, 2021
YouTubeInternational Myeloma Foundation
Talquetamab and Elranatamab: Bispecific Antibodies in Relapsed/…
Oct 20, 2023
targetedonc.com
Talquetamab, Cevostamab and Elranatamab in RRMM | OncLive
Aug 4, 2022
onclive.com
12:26
ELREXFIO (elranatamab) for Multiple Myeloma: Patient Story + …
807 views1 month ago
YouTubeInternational Myeloma Foundation
7:02
Elranatamab in Transplant-Ineligible Newly Diagnosed Multiple Myelom…
401 views8 months ago
YouTubeInternational Myeloma Foundation
Dr Mohty on Extended Follow-up Data from MagnetisMM-3 With Elra…
Jun 10, 2023
onclive.com
4:39
What is the clinical experience with elranatamab for the treatment of …
303 viewsFeb 25, 2025
YouTubeMultiple Myeloma Hub
1:06
Comparing elranatamab with real-world therapies in triple-class-refr…
43 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
Comparing Teclistamab, Elranatamab, and Linvoseltamab i…
4 months ago
vumedi.com
1:47
What is the clinical experience with elranatamab for the treatment of M…
715 views9 months ago
YouTubeMultiple Myeloma Hub
9:39
Tocilizumab's Role in Protecting Multiple Myeloma Patients on Bisp…
467 viewsJan 21, 2025
YouTubeInternational Myeloma Foundation
3:59
Real-World Evidence and Selecting Optimal Bispecifics in Multiple My…
Feb 5, 2024
onclive.com
2:43
Bispecifics Part 4: The Science of Bispecific Antibodies
1.7K viewsFeb 7, 2023
YouTubeInternational Myeloma Foundation
2:47
Implementing bispecific antibody therapy for R/R myeloma and lym…
71 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:53
Outcomes of bispecific T-cell engager therapy for frail patients …
64 viewsDec 10, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:52
Elranatamab + Carfilzomib: Results in Relapsed/Refractory #Myeloma …
377 viewsDec 13, 2024
YouTubeHealthTree Foundation
2:08
Elrexfio — Targeted therapy for multiple myeloma treatment.
131 views4 months ago
YouTubeMediverse
3:34
Exciting results for BCMA/CD3 bispecific elranatamab (PF-3135) i…
701 viewsJan 24, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:24
Elranatamab vs real-world treatments in triple-class refractor…
126 viewsJan 23, 2025
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:13
Real-World Elranatamab in Elderly, Frail Myeloma Patients: What It Me…
1 views3 months ago
YouTubeInfinite Horizons Media
3:28
The importance of BCMA-targeting ADCs and bispecific antibodies in …
151 viewsDec 1, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:49
The benefit of bispecific antibodies & CAR-T therapy in triple class-ex…
122 viewsJul 10, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder